Amy McBride-Wendell

Amy A. McBride-Wendell currently works at Por Christo, as Chairman, Baxter International, Inc., as Independent Director from 2019, Hologic, Inc., as Lead Independent Director, Axogen, Inc., as Lead Independent Director from 2016, Baxter Healthcare Ltd. (United Kingdom), as Director from 2019, Baxter SpA, as Director from 2019, Baxter Healthcare Pty Ltd., as Director, and Solventum Corp., as Director from 2024.
Ms. McBride-Wendell also formerly worked at Ekso Bionics Holdings, Inc., as Independent Non-Employee Director from 2016 to 2018, Ekso Bionics, Inc., as Director, Covidien New Zealand Ltd., as SVP-Strategy & Business Development in 2007, Covidien Unlimited Co., as SVP-Strategy, Business Development & Licensing from 2006 to 2015, Kendall Healthcare Products, as VP-Tyco Healthcare Business Development, Medtronic Plc, as Senior Vice President-Strategy from 2006 to 2015, and Medtronic Plc (Minnesota), as Senior VP-Strategy & Business Development.
Ms. McBride-Wendell received her undergraduate degree in 1983 from Lawrence Technological University and graduate degree in 1986 from the University of Illinois.